Xue S - Search Results

1

LncSNHG14 promotes the development and progression of bladder cancer by targeting miRNA-150-5p.

Li J, Wang AS, Wang S, Wang CY, Xue S, Guan H, Li WY, Ma TT, Shan YX. Li J, et al. Among authors: xue s. Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1022-1029. doi: 10.26355/eurrev_201902_16989. Eur Rev Med Pharmacol Sci. 2019. PMID: 30779068 Free article.

2

Death-inducer obliterator 1 (DIDO1) silencing suppresses growth of bladder cancer cells through decreasing SAPK/JNK signaling cascades.

Li J, Wang AS, Wang S, Wang CY, Xue S, Li WY, Ma TT, Shan YX. Li J, et al. Among authors: xue s. Neoplasma. 2020 Sep;67(5):1074-1084. doi: 10.4149/neo_2020_191115N01171. Epub 2020 Jun 2. Neoplasma. 2020. PMID: 32484699

3

MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.

Zhang J, Wang S, Han F, Li J, Yu L, Zhou P, Chen Z, Xue S, Dai C, Li Q. Zhang J, et al. Among authors: xue s. Gene. 2016 Apr 1;579(2):146-52. doi: 10.1016/j.gene.2015.12.048. Epub 2015 Dec 23. Gene. 2016. PMID: 26723509

4

LncRNA NBAT1 suppresses cell proliferation and migration via miR-346/GSK-3β axis in renal carcinoma.

Xue S, Wang S, Li J, Guan H, Jiang S, Guo Y, Li Q. Xue S, et al. IUBMB Life. 2019 Nov;71(11):1720-1728. doi: 10.1002/iub.2111. Epub 2019 Jul 12. IUBMB Life. 2019. PMID: 31298469 Free article.

5

Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.

Wang S, Li Q, Wang K, Dai Y, Yang J, Xue S, Han F, Zhang Q, Liu J, Wu W. Wang S, et al. Among authors: xue s. Clin Transl Oncol. 2013 Oct;15(10):849-54. doi: 10.1007/s12094-013-1014-4. Epub 2013 Feb 14. Clin Transl Oncol. 2013. PMID: 23408039

6

Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.

Xue S, Jiang SQ, Li QW, Wang S, Li J, Yang S, Zhang HM, Xu YF, Wang LS, Zheng JH. Xue S, et al. BMC Urol. 2018 Sep 10;18(1):79. doi: 10.1186/s12894-018-0395-7. BMC Urol. 2018. PMID: 30200918 Free PMC article.

7

Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.

Wang S, Xue S, Dai Y, Yang J, Chen Z, Fang X, Zhou W, Wu W, Li Q. Wang S, et al. Among authors: xue s. Diagn Pathol. 2012 Nov 22;7:159. doi: 10.1186/1746-1596-7-159. Diagn Pathol. 2012. PMID: 23173870 Free PMC article.

8

KLF13 loss-of-function variation contributes to familial congenital heart defects.

Wang SS, Wang TM, Qiao XH, Huang RT, Xue S, Dong BB, Xu YJ, Liu XY, Yang YQ. Wang SS, et al. Among authors: xue s. Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):11273-11285. doi: 10.26355/eurrev_202011_23617. Eur Rev Med Pharmacol Sci. 2020. PMID: 33215447 Free article.

9

Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.

Xue S, Li QW, Che JP, Guo Y, Yang FQ, Zheng JH. Xue S, et al. Int J Clin Exp Pathol. 2015 Apr 1;8(4):3765-74. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26097558 Free PMC article.

10

DNA-methylation-mediated repression of miR-766-3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma.

Chen C, Xue S, Zhang J, Chen W, Gong D, Zheng J, Ma J, Xue W, Chen Y, Zhai W, Zheng J. Chen C, et al. Among authors: xue s, xue w. Int J Cancer. 2017 Nov 1;141(9):1867-1878. doi: 10.1002/ijc.30853. Epub 2017 Aug 8. Int J Cancer. 2017. PMID: 28657135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,284 results

Search Page

Filters